🔎 Trials Near Me

Akèy › Melanom › Tennessee › Memphis

Etid klinik pou Melanom nan Memphis, TN

11 etid pou Melanom ap chèche patisipan nan sit nan ak bò kote Memphis (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.

Ap rekriteFaz 3
  • Baptist Cancer Center, Bartlett · 11 mi lwen
Laj 18 a 70 · Tout sèks · Mizajou Sep 24, 2026 · NCT05727904

A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information

Ap rekriteFaz 2
  • Saint Jude Children's Research Hospital, Memphis
Jiska laj 25 · Tout sèks · Mizajou Sep 24, 2026 · NCT07621614

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Ap rekriteFaz 1/2
  • Saint Jude Children's Research Hospital, Memphis
12 Months – 30 Years · Tout sèks · Mizajou Aug 25, 2026 · NCT04851119

Project: Every Child for Younger Patients With Cancer

Ap rekriteEtid obsèvasyon
  • Saint Jude Children's Research Hospital, Memphis
Jiska laj 25 · Tout sèks · Mizajou Aug 25, 2026 · NCT02402244

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

Ap rekriteFaz 1/2
  • The West Clinic, Germantown · 14 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 5, 2026 · NCT06330064

Familial Investigations of Childhood Cancer Predisposition

Ap rekriteEtid obsèvasyon
  • St. Jude Children's Research Hospital, Memphis
Tout laj · Tout sèks · Mizajou Jun 17, 2026 · NCT03050268

B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)

Ap rekriteFaz 1
  • St. Jude Children's Research Hospital, Memphis
Jiska laj 21 · Tout sèks · Mizajou May 19, 2026 · NCT04897321

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

Ap rekriteFaz 2/3
  • The West Clinic, PLLC dba West Cancer Center, Germantown · 14 mi lwen
Tout laj · Tout sèks · Mizajou Apr 2, 2026 · NCT06581406

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Ap rekriteEtid obsèvasyon
  • Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
  • Baptist Memorial Hospital for Women, Memphis
  • Baptist Memorial Hospital and Cancer Center-Desoto, Southaven · 11 mi lwen
  • ak 1 plis
Laj 18 ak plis · Tout sèks · Mizajou Mar 17, 2026 · NCT06418204

Molecular Analysis of Childhood and Adolescent Melanocytic Lesions

Ap rekriteEtid obsèvasyon
  • St. Jude Children's Research Hospital, Memphis
Jiska laj 18 · Tout sèks · Mizajou Nov 10, 2025 · NCT02775643

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon
  • Massive Bio SYNERGY-AI site, Memphis
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

Etid Melanom nan lòt vil

Lòt etid nan Memphis

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.